Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8598 |
High Similarity |
NPD7228 |
Approved |
0.8509 |
High Similarity |
NPD6234 |
Discontinued |
0.8477 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD37 |
Approved |
0.8408 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8385 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8385 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8385 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8373 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8198 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8166 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8148 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD7054 |
Approved |
0.807 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.807 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8059 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8049 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7977 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7976 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7961 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7843 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7818 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7806 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7803 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7758 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7753 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7705 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7688 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7634 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7632 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7616 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7547 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7531 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7528 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2801 |
Approved |
0.75 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7484 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7456 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7407 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7346 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7337 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5402 |
Approved |
0.725 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7232 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD5588 |
Approved |
0.72 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7173 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2797 |
Approved |
0.716 |
Intermediate Similarity |
NPD6032 |
Approved |
0.716 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7152 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD447 |
Suspended |
0.712 |
Intermediate Similarity |
NPD6841 |
Approved |
0.712 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.712 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7093 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7093 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7077 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7044 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7041 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD919 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7024 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD27 |
Approved |
0.7022 |
Intermediate Similarity |
NPD2489 |
Approved |
0.702 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7 |
Intermediate Similarity |
NPD7157 |
Approved |
0.6995 |
Remote Similarity |
NPD7312 |
Approved |
0.6995 |
Remote Similarity |
NPD7310 |
Approved |
0.6995 |
Remote Similarity |
NPD7313 |
Approved |
0.6995 |
Remote Similarity |
NPD7311 |
Approved |
0.6994 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6994 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD4626 |
Approved |
0.6989 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6985 |
Remote Similarity |
NPD7930 |
Approved |
0.6973 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6971 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD2969 |
Approved |
0.6966 |
Remote Similarity |
NPD2970 |
Approved |
0.6964 |
Remote Similarity |
NPD6799 |
Approved |
0.6961 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD228 |
Approved |
0.6957 |
Remote Similarity |
NPD7309 |
Approved |
0.6954
|
Remote Similarity |
NPD7874 |
Approved |